Overview

Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study will help to show the efficacy of vitamin D and address the optimal strategy to minimize renal injury in IgAN patients.
Phase:
N/A
Details
Lead Sponsor:
Yonsei University
Treatments:
Calcitriol